Delivery Order SPE2DE21D0005-SPE2D625F1YT6

Award Date 6/11/25
Potential Completion Date 6/16/25
Potential Value $2.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products based in Canton, Massachusetts. The contract is a delivery order for the APLIGRAF skin substitute product, with a period of performance through May 1, 2025. This award is not associated with a set-aside designation, indicating Organogenesis competes as a standard commercial vendor....
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This federal contract award is to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, valued at $2,479.90, is a delivery order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The award is for the supply of the APLIGRAF advanced wound care product, a specialized skin substitute and tissue regeneration solution used in medical treatments. The contract does not utilize any set-aside...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, valued at $1,239.95, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical and the Department of Veterans Affairs (VA) for the supply of APLIGRAF, a skin substitute product. The contract has not utilized any set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration for military personnel and veterans. Organogenesis is an established vendor for the Department of Veterans Affairs (VA) and DLA, holding several significant federal...
This federal contract award, valued at $3,719.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for the medical product APLIGRAF, a skin substitute. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for surgical implants, a $30 million...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order, with a Ceiling Value of $1,239.95, and a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of April 17, 2025. Organogenesis Inc. is a for-profit...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, is a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F35N5) placed by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of APLIGRAF, an advanced wound care product. The award is not associated with a set-aside program and is a Fixed Price with Economic Price Adjustment contract type. Organogenesis has a strong track record of providing...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F1YT6
    Delivery Order

This federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, is a $2,479.90 Delivery Order for the supply of APLIGRAF, a skin substitute product. The contract is funded by the Defense Logistics Agency (DLA) and does not utilize a set-aside designation, indicating Organogenesis competes as a standard commercial vendor.

The award is associated with Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for Surgical Implant Next Generation products, a $30 million multiple-award Federal Supply Schedule contract, and a $49.5 million multiple-award Indefinite Delivery Contract with the DLA for wound care dressings and medical supplies. These contract vehicles enable Organogenesis to provide a comprehensive range of regenerative medicine products to support medical treatments across military and veteran healthcare programs.

Generated 9/10/25, 9:51 AM